1 |
11c-acetate |
Acetate |
- |
- |
- |
013 [3] 13, 86, 88 💬 |
2 |
[18f]fluoro-2-deoxy-2-d-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
086 [2] 86, 88 💬 |
3 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
4 |
Act-064992 |
- |
- |
- |
- |
051 [5] 51, 85, 86, 88, 210 💬 |
5 |
Act-293987 |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
6 |
Adempas |
- |
- |
- |
- |
051 [5] 51, 86, 88, 225, 299 💬 |
7 |
Adempas (riociguat, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [2] 86, 88 💬 |
8 |
Adempas® |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
9 |
Ambrisentan |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [7] 51, 84, 85, 86, 88, 210, 211 💬 |
10 |
Ambrisentan 5 mg |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
088 [1] 88 💬 |
11 |
Ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [4] 6 , 17, 86, 88 💬 |
12 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
13 |
Barnascan |
- |
- |
- |
- |
088 [1] 88 💬 |
14 |
Bay 63-2521 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
15 |
Bay 63-2521 coated tablets 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
16 |
Bay 63-2521 coated tablets 1 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
17 |
Bay 63-2521 coated tablets 1.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
18 |
Bay 63-2521 coated tablets 2 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
19 |
Bay 63-2521 coated tablets 2.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
20 |
Bay 63-2521 ir coated tablet 1.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
21 |
Bay 63-2521 ir coated tablet 1.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
22 |
Bay 63-2521 ir coated tablet 2.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
23 |
Bay 63-2521 ir coated tablet 2.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
24 |
Bay 63-2521 ir tablet 0.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
25 |
Bay 63-2521 ir tablet 1.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
26 |
Bay 63-2521 ir tablet 1.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
27 |
Bay 63-2521 ir tablet 2.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
28 |
Bay 63-2521 ir tablet 2.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
29 |
Bay 63-2521 tablets 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
30 |
Bay 63-2521 tablets 1 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
31 |
Bay 63-2521 tablets 1.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
32 |
Bay 63-2521 tablets 2 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
33 |
Bay 63-2521 tablets 2.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
34 |
Bay1237592 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
35 |
Behavioral: respiratory and exercise therapy |
- |
- |
- |
- |
088 [1] 88 💬 |
36 |
Behavioral: respiratory and exercise therapy with supplemental oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
37 |
Bosentan |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
38 |
Bosentan monohydrate |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [4] 51, 84, 86, 88 💬 |
39 |
Bpa |
- |
- |
- |
- |
088 [1] 88 💬 |
40 |
Cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [11] 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
41 |
D-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
049 [3] 49, 86, 88 💬 |
42 |
Diagnostic test: endogenous thrombin potential |
Thrombin |
[1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
43 |
Diagnostic test: light transmission aggregometry |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
44 |
Diagnostic test: platelet function analyzer-100 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
45 |
Diagnostic test: rotational thromboelastometry |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
46 |
Edoxaban |
Edoxaban |
[2] D09546 D09546, D09710 D09710 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
046 [2] 46, 88 💬 |
47 |
Fludeoxyglucose |
Fludeoxyglucose |
[1] D01843 D01843 💬 |
- |
- |
034 [4] 34, 84, 85, 88 💬 |
48 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
49 |
Gsk1325760 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
50 |
Imatinib |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
51 |
Imatinib mesilate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [3] 13, 86, 88 💬 |
52 |
Iodine |
Iodine |
[1] D00108 D00108 💬 |
- |
- |
046 [2] 46, 88 💬 |
53 |
Jnj-67896062 / act-064992 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
54 |
Macitentan |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [5] 51, 85, 86, 88, 210 💬 |
55 |
Macitentan 10 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 86, 88 💬 |
56 |
Macitentan tablets |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [2] 86, 88 💬 |
57 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
58 |
Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
59 |
Multihance |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
60 |
N-acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
013 [7] 13, 19, 34, 85, 88, 296, 310 💬 |
61 |
Ns-304 |
- |
- |
- |
- |
070 [3] 70, 86, 88 💬 |
62 |
Ns-304 placebo |
- |
- |
- |
- |
070 [2] 70, 88 💬 |
63 |
Opsumit |
- |
- |
- |
- |
086 [3] 86, 88, 210 💬 |
64 |
Opsumit® |
- |
- |
- |
- |
086 [3] 86, 88, 210 💬 |
65 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
66 |
Oxygen, liquid |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [2] 86, 88 💬 |
67 |
Ph-combination therapy |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
68 |
Ph-monotherapy |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
69 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
70 |
Procedure: ballon pulmonary angioplasty |
- |
- |
- |
- |
088 [1] 88 💬 |
71 |
Procedure: balloon pulmonary angioplasty (bpa) |
- |
- |
- |
- |
088 [1] 88 💬 |
72 |
Procedure: long term oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
73 |
Procedure: no gas |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
74 |
Procedure: pulmonary endarterectomy |
- |
- |
- |
- |
088 [1] 88 💬 |
75 |
Procedure: pulmonary endarteriectomy |
- |
- |
- |
- |
088 [1] 88 💬 |
76 |
Procedure: supplemental oxygen via a mask |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
77 |
Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3) |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
088 [1] 88 💬 |
78 |
Radiation: computed tomography lung subtraction iodine mapping |
Iodine |
[1] D00108 D00108 💬 |
- |
- |
088 [1] 88 💬 |
79 |
Remodulin |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
80 |
Remodulin (r) |
- |
- |
- |
- |
088 [1] 88 💬 |
81 |
Remodulin 10mg/ml 20ml |
- |
- |
- |
- |
088 [1] 88 💬 |
82 |
Remodulin 1mg/ml 20ml |
- |
- |
- |
- |
088 [1] 88 💬 |
83 |
Remodulin 2.5mg/ml 20ml |
- |
- |
- |
- |
088 [1] 88 💬 |
84 |
Remodulin 5mg/ml 20ml |
- |
- |
- |
- |
088 [1] 88 💬 |
85 |
Riociguat |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [6] 51, 84, 86, 88, 225, 299 💬 |
86 |
Riociguat (adempas, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [4] 51, 86, 88, 299 💬 |
87 |
Riociguat oral tablet |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
088 [1] 88 💬 |
88 |
Ro 47-0203 |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
89 |
Sauerstoff |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
90 |
Selexipag |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [5] 51, 70, 84, 86, 88 💬 |
91 |
Thrombin |
Thrombin |
[1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
92 |
Tracleer |
- |
- |
- |
- |
013 [8] 13, 51, 84, 85, 86, 88, 210, 211 💬 |
93 |
Tracleer 125mg 56cpr riv. |
- |
- |
- |
- |
088 [1] 88 💬 |
94 |
Tracleer*56cpr riv 125mg |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
95 |
Treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [6] 51, 84, 85, 86, 88, 210 💬 |
96 |
Treprostinil sodium |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [3] 51, 86, 88 💬 |
97 |
Uptravi |
- |
- |
- |
- |
084 [3] 84, 86, 88 💬 |
98 |
Volibris |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
99 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |